EXPERT REACTION: Smoking dope just once as a teen could change your brain

Embargoed until: Publicly released:

Teens who say they have only smoked cannabis once or twice have both structural and cognitive changes in their brains, compared with teens who have never smoked dope, according to a small Australian-led study. The researchers used brain scans of 46 14-year-olds and found a greater volume of grey matter in some brain regions among the teens with just one or two instances of cannabis use compared with those who had never tried the drug. The researchers also found a link between these changes in grey matter and assessments of reasoning and anxiety.

Journal/conference: JNeurosci

Link to research (DOI): 10.1523/JNEUROSCI.3375-17.2018

Organisation/s: Swinburne University of Technology

Funder: This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT-2007-037286), the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY' (Brain network based stratification of reinforcement-related disorders) (695313), ERANID (Understanding the Interplay between Cultural, Biological and Subjective Factors in Drug Use Pathways) (PR-ST-0416-10004), BRIDGET (JPND: BRain Imaging, cognition Dementia and next generation GEnomics) (MR/N027558/1), the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EUAIMS (115300-2), the Medical Research Council Grant 'c-VEDA' (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the Swedish Research Council FORMAS, the Medical Research Council, the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc01ZX1311A; Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-1, SM 80/7-2, SFB 940/1), and the Fondation pour la Recherche Médicale (DPA20140629802), the Fondation de l'Avenir. Further support was provided by grants from: ANR (project AF12-NEUR0008-01 - WM2NA, and ANR-12-SAMA-0004), the Fondation de France, the Fondation pour la Recherche Médicale, the Mission Interministérielle de Lutte-contre-les-Drogues-et-les- Conduites-Addictives (MILDECA), the Assistance-Publique-Hôpitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), U.S.A. (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1), and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. RR is supported by Dana Foundation David Mahoney program and CTSA Grant Number UL1 TR001863 from the National Center for Advancing Translational Science (NCATS), components of the National Institutes of Health (NIH), and NIH roadmap for Medical Research.

Media Release

From: Society for Neuroscience

A Little Weed Can Change the Teenage Brain

Teenagers who report using recreational marijuana just once or twice display increased volume of numerous brain regions, according to a study of 14-year-olds from Ireland, England, France, and Germany. The research, published in JNeurosci, warrants further study of low-level cannabis use among adolescents amid changing societal attitudes toward the drug.

Analyzing data from a large research program investigating adolescent brain development and mental health, Catherine Orr and colleagues identified brain regions rich in cannabinoid receptors that underwent structural changes in teenagers who reported limited cannabis use. These differences persisted despite controlling for many variables, including sex and socioeconomic status as well as alcohol and nicotine use, and were only apparent after cannabis use. Finally, the researchers demonstrate associations between increased grey matter volume in low-level cannabis users and assessments of reasoning and anxiety.

Given the important role of the endogenous cannabinoid system in brain development during adolescence, teenagers may be particularly vulnerable to the effects of THC, the primary psychoactive component of marijuana. Additional research is needed to determine whether these findings apply to more diverse populations beyond the four European countries studied here.

Attachments:

Note: Not all attachments are visible to the general public

  • Society for Neuroscience
    Web page
    Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Dr Bernie Cocks is a lecturer in cognitive neuroscience at the University of New England

The results of this study suggest that even in small doses, cannabis use can result in structural brain changes, most notably increased grey matter volume. 

Given that adolescence is a time of rapid brain maturation/reorganisation, any changes which are induced by external forces such as cannabis or alcohol use rather than normal developmental factors must be viewed with some concern.

The study also noted a large degree of overlap between low-dose users and non-users, suggesting that some individuals may be more at risk than others, although it is not yet possible to identify those at-risk. 

As a consequence, the overall results suggest that cannabis, like alcohol and other recreational drugs, should be avoided until brain development/maturation is complete; that is, until at least the age of 21.

Paradoxically, the finding that low-dose cannabis use can increase grey matter volume may have therapeutic implications.  Previous studies have suggested that some individuals suffering from some disorders (e.g. major depressive disorder) have reduced grey matter volume, thus, low dose  cannabis use, under medical supervision, may have the potential to reverse this reduction, although a significant amount of research needs to be conducted before such a conclusion can be verified either way.

Last updated: 14 Jan 2019 1:23pm
Declared conflicts of interest:
None declared.
Dr Liz Temple is a Senior Lecturer in Psychology at the University of New England

While many past survey-based studies have found that using cannabis before the age of 16 is linked to a range of adverse outcomes, this new research by Catherine Orr and colleagues increases our understanding of how and why this may occur.  In particular, it provides biological evidence that, even when used only once or twice, cannabis use can adversely impact the brains of young teenagers.

It is, however, important to note that the study found only a small number of cognitive functions and behaviours to be associated with these cannabis use-related brain alterations, with many of the assessed cognitive functions and behaviours being unaffected. 

It is also important, as noted by the researchers, that further research is conducted to ensure findings can be replicated in larger and more diverse samples.

More in-depth investigation of the concurrent use of cannabis, alcohol and nicotine on the adolescent brain is also important, to increase our understanding of the individual and combined impacts of these substances on normal brain development and function.   

Last updated: 14 Jan 2019 1:19pm
Declared conflicts of interest:
None declared.
Professor Mathew Martin-Iverson is Head of Pharmacology at the University of Western Australia

This is an interesting finding of increased gray matter volume in the brains of young people who tried cannabis once or twice when they were 14. The data are from a small subset of a much larger multi-centre study that was focused on different issues.

The findings are an association, and the direction of cause cannot be determined by this study.

It may be other factors, such as the age at which nicotine or alcohol were first tried, or other personality or environmental characteristics that were not reported in the study that may lead to early experimentation that are causal to the gray matter volume changes, if the effect is real.

Note that the same effect was not apparent in 16-year-olds who tried cannabis once or twice. The sample sizes are relatively limited and the relative low rate of replication of the findings (e.g., https://www.bbc.com/news/science-environment-39054778) means that we need  replication in other samples before we can be confident that the association exists.

Furthermore, the significance levels were not corrected for the large number of comparisons made, which has led to positive findings in a MR brain imaging in a dead salmon brain.

It is also unclear what significance an increase in gray matter volume may have. Is it good or bad? In the past, decreases in gray matter volume were associated with alcoholism and schizophrenia, for example.

This study raises more questions than it answers at this stage.

Last updated: 14 Jan 2019 11:50am
Declared conflicts of interest:
None declared.

Professor Darryl Eyles is Director of the Neurobiology Laboratory at the Queensland Brain Institute, University of Queensland

Along with stress, THC exposure is one of the most prominent risk factors for schizophrenia. In general the earlier the use, the greater the risk.

Therefore this paper imaging teenage brains exposed to THC is an important contribution, especially as sample numbers are relatively large for imaging studies and this is a non-standard population.

The first cohort of THC-exposed and non-exposed teens is well matched. The study design has been careful to include a second longitudinal cohort examining baseline brain structures. This allows not only the ability to examine whether there is change from baseline (assumed to be mediated by THC) but, perhaps even more importantly, allows the reader to assess whether the brains of those who chose to use cannabis were somehow different to start with; i.e do those who use drugs belong to a separate “risk taking” population.

This definitely strengthens the interpretations of these findings - that it is the drug rather than a prior alteration in risk taking individuals driving the findings.

An increase in grey matter is counter to most findings in THC users and schizophrenia, where most brain volume imaging studies reveal decreases. It is difficult for the authors to determine mechanism driving this initial volume increase and follow up scans on those who become dependent would be very informative.

Limitations:

The issue of scanner variation is not insignificant and perhaps requires the delta GMVs [gray matter volume] data to be re-examined with users and controls matched at the same site. The data in cohort two, however, are longitudinal and presumably at the same site so this is perhaps less of an issue.

Another possible limitation is the active nature of use; i.e. was use recent or proximal to the scan. A drug urine screen could be suggested to control for this.

An increase in brain volumes of course may still be a benign feature related to the pharmacology of CB1 receptor activation in various brain regions, i.e. greater dendritic densities, glial hypertrophy or increased glial number, increased spine numbers. These are all dynamic events and presumably able to come back to some sort of equilibrium in the absence of stimuli, in this case THC. The minimal exposure associated with these findings is perhaps the most important result as it speaks to the long-standing nature of these effects on the adolescent brain.

I think this is a well conducted study that makes an important contribution to our knowledge about adolescent brains.

Last updated: 14 Jan 2019 11:56am
Declared conflicts of interest:
None declared.

News for:

Australia
VIC

Media contact details for this story are only visible to registered journalists.